Telisotuzumab Vedotin Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Telisotuzumab vedotin (Teliso-V) is an antibody drug conjugate that targets the MET receptor.

Clinical Use

In the first in-human phase I trial for Teliso-V, NSCLC patients with MET-overexpressing tumors received monotherapy. The results of this innovative trial indicated favorable safety and tolerability responses and also showed promising antitumor activity in NSCLC patients with MET overexpression.

Telisotuzumab Vedotin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Telisotuzumab Vedotin Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.		support@targetmol.com	United States	38631	58
DC Chemicals	021-58447131 13564518121	sales@dcchemicals.com	China	9409	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10424	58
bioleaper	4000880777 17585207275	guojing@bioleaper.com	China	5616	58

---

• Telisotuzumab Vedotin
• 1714088-51-3